Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis
Emanuela Abiusi, Alessandro Vaisfeld, Stefania Fiori, et al.
Journal of Medical Genetics (2022) Vol. 60, Iss. 7, pp. 697-705
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies
Ilaria Angilletta, Rossella Ferrante, Roberta Giansante, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14873-14873
Open Access | Times Cited: 25
Spinal Muscular Atrophy Update in Best Practices
Mary Schroth, J. Deans, Kapil Arya, et al.
Neurology Clinical Practice (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 12
Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg
Anton Kiselev, Marianna Maretina, Sofia Shtykalova, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 1, pp. 9-9
Open Access | Times Cited: 7
Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy
Katy Cooper, Gamze Nalbant, Anthea Sutton, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 49-49
Open Access | Times Cited: 7
Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years
Tomokazu Kimizu, Masatoshi Nozaki, Yousuke Okada, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 314-314
Open Access | Times Cited: 5
Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns
Irina Yu. Efimova, Р. А. Зинченко, Andrey V. Marakhonov, et al.
Pediatric Neurology (2024) Vol. 156, pp. 147-154
Closed Access | Times Cited: 5
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians
Sithara Ramdas, Maryam Oskoui, Laurent Servais
Drugs (2024) Vol. 84, Iss. 7, pp. 747-762
Closed Access | Times Cited: 5
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience
Delia Gagliardi, Eleonora Canzio, Paola Orsini, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 5, pp. 1090-1096
Open Access | Times Cited: 4
Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium
Tamara Dangouloff, Kristine Hovhannesyan, Davood Mashhadizadeh, et al.
Children (2024) Vol. 11, Iss. 8, pp. 926-926
Open Access | Times Cited: 4
Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation
Kristina Mikhalchuk, Olga Shchagina, А. Л. Чухрова, et al.
International Journal of Neonatal Screening (2023) Vol. 9, Iss. 2, pp. 29-29
Open Access | Times Cited: 10
Pushing the boundaries: future directions in the management of spinal muscular atrophy
Fiona Moultrie, Laura Chiverton, Isabel Hatami, et al.
Trends in Molecular Medicine (2025)
Open Access
Spinal muscular atrophy in the era of newborn screening: how the classification could change
Antonio Varone, Gabriella Esposito, Ilaria Bitetti
Frontiers in Neurology (2025) Vol. 16
Open Access
Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective
Lakshmi Balaji, Michelle A. Farrar, Arlene D’Silva, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 7, pp. 571-586
Closed Access | Times Cited: 8
Newborn screening programs for spinal muscular atrophy worldwide in 2023
Eva Vrščaj, Tamara Dangouloff, Damjan Osredkar, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 6, pp. 1180-1189
Closed Access | Times Cited: 3
Neonatal screening for spinal muscular atrophy: A pilot study in Brazil
Alice Brinckmann Oliveira Netto, Ana Carolina Brusius‐Facchin, Júlia F. Lemos, et al.
Genetics and Molecular Biology (2023) Vol. 46, Iss. 3 suppl 1
Open Access | Times Cited: 8
Analysis of genomics implementation in newborn screening for inherited metabolic disorders: an IRDiRC initiative
Guillem Pintos‐Morell, Maria Iascone, Giorgio Casari, et al.
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 2, pp. 19-19
Open Access | Times Cited: 2
Treatment of spinal muscular atrophy
Maria Carmela Pera, Eugenio Mercuri
Current Opinion in Pediatrics (2024) Vol. 36, Iss. 6, pp. 612-618
Closed Access | Times Cited: 2
270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10–12 March, 2023, Hoofddorp, the Netherlands
Emanuela Abiusi, Mar Costa‐Roger, Enrico Bertini, et al.
Neuromuscular Disorders (2023) Vol. 34, pp. 114-122
Open Access | Times Cited: 6
A high-fidelity long-read sequencing-based approach enables accurate and effective genetic diagnosis of spinal muscular atrophy
Jin-li Bai, Yu-jin Qu, Wen‐Chen Huang, et al.
Clinica Chimica Acta (2023) Vol. 553, pp. 117743-117743
Closed Access | Times Cited: 6
Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy
Marie Beaudin, Tahereh Kamali, Whitney Tang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6696-6696
Open Access | Times Cited: 4
Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy through Newborn Screening
Vanessa Luiza Romanelli Tavares, Rodrigo Holanda Mendonça, Maytê S. Toledo, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 858-858
Open Access | Times Cited: 1
Spinal muscular atrophy
Megan A. Waldrop, Stephen J. Kolb, John T. Kissel, et al.
Elsevier eBooks (2024), pp. 495-517
Closed Access | Times Cited: 1
Why should a 5q spinal muscular atrophy neonatal screening program be started?
Michele Michelin Becker, Flávia Nardes, Tamara Dangouloff, et al.
Arquivos de Neuro-Psiquiatria (2024) Vol. 82, Iss. 10, pp. 1-9
Open Access | Times Cited: 1
Parental Experiences with Newborn Screening and Gene Replacement Therapy for Spinal Muscular Atrophy
Alayne P. Meyer, Anne M. Connolly, Kathryn Vannatta, et al.
Journal of Neuromuscular Diseases (2023) Vol. 11, Iss. 1, pp. 129-142
Open Access | Times Cited: 3
Newborn screening and rapid genomic diagnosis of neuromuscular diseases
Tamara Dangouloff, H. Lang, Noor Benmhammed, et al.
Journal of Neuromuscular Diseases (2024)
Open Access
Page 1 - Next Page

Scroll to top